References
- Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34: 1–12.
- Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T.How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005; 35: 107–119.
- Buno I, Nava P, Simon A, Gonzalez-Rivera M, Jimenez JL, Balsalobre P et al. A comparison of fluorescent in situ hybridiza-tion and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica 2005; 90: 1373–1379.
- Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, SpitzerT, Weisdorf D. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplantation. Biol Blood Marrow Transplant 2001; 7: 473–485.
- Schichman SA, Suess P, Vertino AM, Gray PS. Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment. Bone Marrow Transplant 2002; 29: 243–248.
- Fernandez-Aviles F, Urbano-Ispizua A, Aymerich M, Colomer D,Rovira M, Martinez C et al. Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34 + selected cells from peripheral blood. Leukemia 2003; 17: 613–620.
- Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immu-notherapy may be effective. Bone Marrow Transplant 2004; 33: 815–821.
- Balon J, Halaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L, Piekarska A et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 2005; 35: 1083–1088.
- Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99: 4618–4625.
- Thiede C, Bornhauser M, Oelschlagel U, Brendel C, Leo R, Daxberger H et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001; 15: 293–302.
- Lee KH, Lee JH, Choi Si, Lee JH, Kim S, Seol M et al. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2003; 32: 423–431.
- Beck O, Seidl C, Lehrnbecher T, Kreyenberg H, Schwabe D, Klingebiel T et al. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur J Haematol 2006; 76: 237–244.
- Millson AS, Spangler FL, Wittwer CT, Lyon E. Comparison of automated short tandem repeat and manual variable number of tandem repeat analysis of chimerism in bone marrow transplant patients. Diagn Mol Pathol 2000; 9: 91–97.
- Valcarcel D, Martino R, Caballero D, Mateos MV, Perez-Simon JA, Calans C et al. Chimerism analysis following allogeneic blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2003; 31: 387–392.
- Miura Y, Tanaka J, Toubai T, Tsutsumi Y, Kato N, Hirate D et al. Analysis of donor-type chimerism in lineage-specific cell popula-tions after allogeneic myeloablative and nonmyeloablative stem cell transplantation. Bone Marrow Transplant 2006; 37: 837–843.
- Ikpeazu C, Davidson MK, Halteman D, Goodman SA, Browning Pi, Brandt Si. Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2000; 6: 301–308.